Literature DB >> 30298976

Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis?

Maria F Ruberto1, Francesco Marongiu1, Orazio Sorbello2, Alberto Civolani2, Luigi Demelia1, Doris Barcellona1.   

Abstract

INTRODUCTION: Prothrombin time is thought to be unreliable in cirrhotic patients to predict the risk of bleeding. We investigated whether prothrombin time ratio was an independent risk factor for bleeding alongside its clot waveform analysis.
METHODS: We studied 307 consecutive cirrhotic patients and 115 healthy subjects. A coagulometer was used for detecting both prothrombin time and clot waveform analysis which included velocity (1st derivative) and acceleration (2nd derivative) of clot formation, and area of parabolic segment of the 1st and 2nd derivatives of prothrombin time (entire cycle of the clot formation).
RESULTS: Logistic regression shows that prothrombin time ratio was the only variable significantly associated with the history of bleeding. Using a hemorrhagic score, the stepwise model included prothrombin time ratio and the area of parabolic segment of the 1st derivative of Prothrombin Time. Odds ratio was used to create a new score to be challenged against the hemorrhagic score in a ROC analysis. The AUC was 0.72, 95% CI: 0.67-0.77.
CONCLUSION: Prothrombin time ratio is associated to an increased bleeding risk. Its role may be further emphasized considering clot waveform analysis. The new score, if aggregated to prothrombin time ratio, could be useful to provide a single parameter immediately ready to assess the bleeding risk in the individual cirrhotic patient.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  bleeding; blood coagulation; clot waveform analysis; liver cirrhosis; thrombosis

Mesh:

Year:  2018        PMID: 30298976     DOI: 10.1111/ijlh.12934

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  4 in total

Review 1.  Anticoagulation in patients with advanced liver disease: an open issue.

Authors:  Francesco Violi; Lorenzo Loffredo; Daniele Pastori
Journal:  Intern Emerg Med       Date:  2020-10-18       Impact factor: 3.397

Review 2.  Value of Liver Function Tests in Cirrhosis.

Authors:  Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2021-11-14

3.  Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab.

Authors:  Marina Di Pino; Maria Filomena Ruberto; Giulia Costanzo; Davide Firinu; Maria Sebastiana Piras; Mario Nicola Mura; Stefano Del Giacco; Ferdinando Coghe; Francesco Marongiu; Doris Barcellona
Journal:  Clin Exp Med       Date:  2022-05-25       Impact factor: 5.057

4.  Assessment and establishment of a reference interval for Roche Cobas t 711 coagulation analyzer for a hospital in China.

Authors:  Chi Zhu; Lili Sun; Haowei Li; Zhenghua Dong; Siyuan Yu; Xiaoming Zhao; Ji Yang; Wenjuan Wu
Journal:  Pract Lab Med       Date:  2022-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.